Back to Journals » OncoTargets and Therapy » Volume 16

MicroRNA-381 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma by Targeting X-Linked Inhibitor of Apoptosis Protein [Retraction]

Authors Zhou S, Cui Y, Yu D, Liang J, Zhang M, Ye W

Received 10 May 2023

Accepted for publication 10 May 2023

Published 11 May 2023 Volume 2023:16 Pages 311—312

DOI https://doi.org/10.2147/OTT.S420793



Zhou S, Cui Y, Yu D, Liang J, Zhang M, Ye W. Onco Targets Ther. 2017;10:2527–2538.

The Editor and Publisher of OncoTargets and Therapy are retracting the published article. Concerns were raised regarding the duplication of western blot images and an investigation found duplicated images in Figures 3 and 6. Specifically,

  • The image in Figure 3D, TE10, c-caspase-3, has been duplicated with the same image from Figure 6C, TE10, c-PARP.
  • The image in Figure 3D, TE10, c-PARP has been duplicated with the same image from Figure 3D, TE11, c-PARP.
  • The image in Figure 3D, TE10/miR-381(+), c-caspase-3, has been duplicated with the same image from Figure 3D, TE11/miR-NC(-), Total PARP.
  • The image in Figure 3D, TE11, Total PARP, has been duplicated with the same image from Figure 6C, TE11, Total caspase-3.
  • The image from Figure 6C, TE10/shXIAP(+), c-PARP has been duplicated with the same image from Figure 6C, TE11/shcontrol(-), Total caspase-3.

The authors cooperated with the investigation but were unable to provide a satisfactory explanation regarding the duplicated images and were unable to verify the published work. Therefore, the Editor and Publisher are retracting the article and the authors have been notified.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.